Transplant; Failure, Heart
18
4
5
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (18)
HEARTBiT: Multi-Marker Blood Test for Acute Cardiac Transplant Rejection
XVIVO Heart Perfusion System (XHPS) With Supplemented XVIVO Heart Solution (SXHS)
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
HIIT in Pediatric Heart Transplant Recipients (MedBIKE™)
EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study
Cardiopulmonary Stress Testing (CPET) AlloSure Study
The Hepatitis C Transplant Collaborative
Non-ischaemic Heart Preservation Versus Standard Cold Storage in Human Heart Transplantation
Virtual Remote Physiological Monitoring Program of Children With Heart Disease
Impact of SGLT2 Inhibitors in Heart Transplant Recipients
EASE-SOT Pilot Study
Assessing the Effects of Mechanical Unloading on Repair Version-1
Optimized Peak VO2 in Predicting Advanced HF
Impact of Level and Quality of Immunosuppression on Onset and Pattern of Cardiac Allograft Vasculopathy Evaluated by OCT
Shear Wave Elastography
A Randomized Controlled Trial Comparing Non-ischemic to Ischemic Preservation in Adult Cardiac Transplantation
Utilizing Technology for Optimization of Pain Management and Mobilization in High Risk Cardiac Surgical ICU Patients
Exercise-based Cardiac Rehabilitation Program on Hospitalized Heart Failure Patients Submitted to Cardiac Transplantation